ETHZilla plans to increase its fundraising scale through equity issuance to 10 billion USD to continue accumulating ETH

ChainCatcher news, Strategic ETH Reserve posted on platform X stating that the Nasdaq-listed Ethereum treasury company ETHZilla (formerly 180 Life Sciences Corp.) has revised the sales agreement previously signed with Clear Street, involving the supplemental prospectus and the accompanying prospectus for the issuance of common stock with a par value of $0.0001 per share.

According to the terms of the revised sales agreement, the company will be able to raise up to $10,000,000,000 through the issuance and sale of common stock to support its continued purchase of ETH.